In addition, we selected cisplatin because it is widely used to treat MPM patients (32) and because in our in vitro co-culture system, we found that pretreatment of AB12 cells with cisplatin stimulated the production of IFNg by anti-tumor splenocytes (Figure 6E). The gene discussed is IFNG; the disease is neoplasm.